Avimer Bio Information

Avimer Bio is a biotechnology company developing next-generation protein therapeutics using our proprietary designed protein NanoCage platform. Our breakthrough technology creates fully human nanoparticles with targeted presentation geometries to deliver potent therapeutics for inflammatory, immune, and oncological diseases. Over 50 million Americans suffer from chronic immune and inflammatory diseases, and current drug treatments are failing them. Traditional therapeutic design is limited to one-target, one-binding approaches, but most cellular processes involve simultaneous interactions between multiple protein molecules and coordinated receptor clusters. Avimer Bio's proprietary computational methods are creating novel protein therapeutics that engage their targets through carefully coordinated, avid binding interactions that induce potent agonist responses. Our designed protein cages offer: - Novel Protein Therapeutic NanoCages with targeted presentation geometries - Superior thermal stability, rigidity, and manufacturability - AI-driven rapid optimization for inflammation and immunology applications - Avid display of targeted payloads with ideal geometry for potent activity - Cryo-EM scaffold technology enabling small molecule drug discovery for challenging targets at sub-3 Angstrom resolution We are creating the next generation of biologic agonists for the remittive treatment of severe inflammatory and immune diseases, and partnering with pharma and biotech companies to enable structure determination and small molecule therapeutic design. Nature's Structure for Targeted Medicines®